Relationship between Intra-renal Resistive Index and Markers of Renal Function Status in Type 2 Diabetic Patients in Southern Nigeria
Issue: 2023 - Volume 6 [Issue 1]
Eleki, Beniboba Jenewari
Nephrology Division, Department of Internal Medicine, Rivers State University Teaching Hospital, Port Harcourt, Rivers State, Nigeria.
Robinson, Ebbi Donald *
Interventional Radiology Unit, Department of Radiology, Rivers State University Teaching Hospital, Port Harcourt, Rivers State, Nigeria.
Emem-Chioma, Pedro C.
Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Rivers State, Nigeria.
Department of Radiology, University of Port Harcourt Teaching Hospital, Rivers State, Nigeria.
*Author to whom correspondence should be addressed.
Background: Diabetes mellitus (DM) is a chronic condition requiring global attention. Renal microangiopathy is a life-threatening microvascular complication often leading to derangements in renal function and progressive renal failure. Renal haemodynamic assessment by duplex Doppler ultrasound scan is a non-invasive method of assessing blood flow resistance within the renal vessels. The intra-renal resistive index (IRI) may be a useful tool in predicting pathological derangements of renal functions in diabetic patients.
Materials and Methods: The study was a cross-sectional study involving 142 consecutive adults with type 2 DM enrolled from December 2017–December 2018. Study approval was obtained from the Ethical and Research Committee of the hospital. Urinalysis, spot urine albumin-to-creatinine ratio (UACR), serum creatinine levels were assessed and glomerular filtration rate estimated using Modification of Diet in Renal Disease equation. All participants had duplex Doppler ultrasound of both kidneys to obtain flow velocities from their interlobar arteries for IRI estimation. Results were analysed with Statistical package for social sciences (SPSS version 23) software.
Results: The study comprised of 87 (61.3%) females and 55 (38.7%) males with a mean age of 55.90±11.02 years. Mean duration of diabetes was 9.60±7.05 years. Mean estimated glomerular filtration rate (eGFR) was 79.18±27.69ml/min/1.73m2, with 31 (21.8%) having their eGFR ≤60mls/min/1.73m2. The mean UACR was 153.65±145.56mg/g with 123 (86.6%) participants having moderate to severe albuminuria The mean average IRI was 0.60±0.09. Participants with diabetic nephropathy (DN) had higher IRI than those without DN (p<0.005). Increased IRI was observed in 36(25.3%) of participants. IRI positively correlated with UACR (p < 0.001) and negatively correlated with eGFR (p < 0.001) and demonstrated a linear relationship with both UACR and eGFR. Increased IRI was associated with duration of diabetes and age.
Conclusion: IRI may be a useful non-invasive tool for early detection and risk prediction of DN.
Keywords: Diabetic nephropathy, intra-renal resistive index, urine albumin-creatinine ratio, renal function status
How to Cite
United Nations 68th General Assembly, Rio+20 outcome document: Open working group proposal for sustainable development goals; 2015.
Ki-moon B, Secretary-General’s concluding remarks at Forum on Global health; 2009. Available:http://www.un.org/sg/STATEMENTS/index.asp?nid=3922. Accessed online March 2016.
International Diabetes federation. IDF Diabetes Atlas. Seventh Edition. Brussels, IDF. 2015;12-13.
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-281.
Tang SC, Chan GC, Lai KN. Recent advances in managing and understanding diabetic nephropathy. F1000Res. 2016;5.
Alebiosu CO. Clinical diabetic nephropathy in tropical African population. West Afr J Med. 2003; 22(2):152-155.
Ghaderin SB, Hayati F, Shayanpour S, Mousavi SB. Diabetes and end stage renal disease; a review article on new concepts. J Renal Inj Prev. 2015;4(2):28-33.
Rossing P. Diabetic nephropathy worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep. 2006;6(6):479-83.
Standards of medical care for patients with diabetes mellitus. American Diabetes Association. Diabetes care 2002;25(1):33-49.
Arogundade FA, Barsoum RS. CKD prevention in sub-Saharan Africa: A call for Government, Non- Governmental and community support. Am J kidney Dis. 2008;51:15-23.
Chinenye S. Living with diabetes in Nigeria: The care, cure and prevention. Inaugural lecture series 126. University of Port Harcourt press, Port Harcourt. 2015;25-28p.
Batuman V, Khadori R, Anjana SS, Rebecca JS, Sandeep SS. Diabetic Nephropathy, Medscape. Available:http://emedicine.medscape.com. Accessed online July 2016.
Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. Risk of end stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT: Multiple Risk Factor Intervention Trial. JAMA. 1997;278:2069-2074.
US Renal Data System: USRDS 1999 Annual Data Report. Bethseda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease; 1999. Available:http://www.med.umich.edu/usrds. Accessed online May 2016.
Pugh JA, Medina RA, Cornell JC, Basu S. NIDDM is the major cause of diabetic end stage renal disease: more evidence from tri-ethnic community. Diabetes. 1995;44:1375-1380.
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–787.
Freehaly J, Floege J, Tonelli M, Johnson RJ. Pathogenesis, clinical manifestation and natural history of diabetic nephropathy. Comprehensive clinical nephrology. 5th ed. New York: Elsevier; 357-375.
American Diabetes Association: Hypertension management in adults with diabetes (Position Statement). Diabetes Care. 2004;27(1):65–67.
Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63:225-232.
Vijan S, Stevens DL, Herman WH, Funnell MM, Standiford CJ. Screening, prevention, counselling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice. J Gen Intern Med. 1997;12:567-580.
Ghani AA, Al Waheeb S, Al Sahow A, Hussain N. Renal biopsy in patients with type 2 diabetes mellitus: indications and nature of the lesions. Annals of Saudi Medicine. 2009;29(6):450–453.
Tervaert TW, Mooyart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB et al. pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556-63.
Pham TT, Sim JJ, Kujubu DA, Liu IL, Kumar VA. Prevalence of nondiabetic renal disease in diabetic patients. Am J Nephrol. 2007;27:322–8.
Currie G, McKay G, Delles C. Biomarkers in diabetic nephropathy: Present and future. World J Diabetes. 2014;5(6):763-776.
Basturk T, Ackay M, Albayrak R, Unsal A, Ulas T, Koc Y. Correlation between the Resistive index values of renal and orbital arteries. Kidney Blood Press Res. 2012;35:332-339.
Abdelhamid YM, Fawzy MW, Abd Al-Salam RM, Gouda YM, Salem MM. Relation between resistivity and pulsatility indices of renal and intra-renal arteries and degree of albuminuria in type 2 diabetic patients. kasr Al Ainy Med J. 2017;23:1-5.
Hamano K, Nitta A, Ohtake T, Kobayashi S. Associations of renal vascular resistance with albuminuria and other microangiopathy in type 2 diabetic patients. Diabetes Care. 2008;31:1853–1857.
Kawai T, Kamide K, Onishi M, Yamamoto-Hanasaki H, Baba Y, Hongyo K, et al. Usefulness of the resistive index in renal Doppler ultrasonography as an indicator of vascular damage in patients with risk of atherosclerosis. Nephrol Dial Transplant. 2011;26:3256-3262.
Tushar PR, Tushar BP, Rajashree SK, Kiran MS, Mangesh BP, Yogendra VB. Clinical profile of diabetic nephropathy and correlation with intra-renal resistivity index by duplex ultrasonography. World J Nephrol Urol. 2012;1(4-5):107-114.
Classification and diagnosis of Diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979; 28(12):1039-1057.
The Eight Joint National Committee guidelines for the management of hypertension in adults. Am Fam Physician. 2014;90(7):503-504.
Levy AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular ﬁltration rate from serum creatinine: A new prediction equation: Modiﬁcation of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470.
National Kidney Foundation. KDOQI Clinical practice guideline for chronic kidney disease: evaluation, classification and stratification. Am J Kid Dis. 2002;39:1-226.
Noubiap JJN, Naidoo J, Kengne AP. Diabetic nephropathy in Africa: A systematic review. World J Diabetes. 2015;6(5):759–773.
Kumiko H, Ai N, Takayasu O, Shuzo KI. Associations of renal vascular resistance with albuminuria and other macroangiopathy in type 2 diabetic patients. Diabetes Care. 2008; 31:1853–1857.
Chukwuani U, Chukwuebuni NJ, Digban KA, Yovwin G D. Prevalence and risk factors of microalbuminuria among type 2 diabetes mellitus: A hospital-based study from, Warri, Nigeria. 2016;19(1):16-20.
Chinenye S, Young EE, Onwuchekwa AC. Diabetes Mellitus in the elderly-Niger Delta Experience. Arch Diab & Cardio Med. 2012;1(1):7-11.
Patel V, Shastri M, Gaur N, Jinwala P, Kadam AY. A study in prevalence of diabetic nephropathy in recently detected cases of type 2 diabetes mellitus as evidenced by altered creatinine clearance, urinary albumin and serum creatinine, with special emphasis on hypertension, hypercholesterolemia and obesity. Int JAdv Med. 2018 Apr;5(2):351-355.
Janmohamed MN, Kalluvya SE, Mueller A, Kabangila R, Smart LR, Downs JA, Peck RN. Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania. BMC Nephrol. 2013 Aug 31; 14:183. DOI: 10.1186/1471-2369-14-183. PMID: 24228774; PMCID: PMC3765892.
Onovughakpo-Sakpa OE, Onyeneke EC, Olumese EF. Incidence of diabetic nephropathy in southern Nigeria. Journal of Medical Sciences. 2009; 9(6):264-269.
Nosadini R, Velussi M, Brocco E, Abater-usso C, Carraro A, Piarulli F, et al. Increased renal arterial resistance predicts the course of renal function in type 2 diabetes with microalbuminuria. Diabetes. 2006;55:234-238.
Milovanceva-Popovska M, Dzikova S. Progression of diabetic nephropathy: value of intra-renal resistive index (RI). Prilozi. 2007;28(1):69-79.
Leoncini G, Martinoli C, Viazzi F, Ravera M, Parodi D, Ratto E et al. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS. Pub Med Nephron. 2002;90 (2):169-73.
Marcini.M, Masulli. M, Liuzzi. R, Mainenti. PR, Ragucci. M, Maurea. S et al. Renal duplex sonographic evaluation of type 2 diabetic patients. J Ultrasound Med. 2013;32:1033–1040.
Shirin MI, Sharif MM, Gurung A, Datta A. Resistive index of intra-renal artery in evaluation of diabetic nephropathy. Bangladesh Med Res Counc Bull. 2015;41:125-130.
Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease with emphasis on the stage of incipient nephropathy. Diabetes. 1983;32(2):64-78.
Platt JF, Rubin JM, Ellis JH. Diabetic nephropathy: evaluation with renal duplex Doppler US. Radiology. 1994;190 (2):343-346.
Abd El Dayem S, El Bohy A, Hamed M, Ahmed S. Follow up of value of the intrarenal resistivity indices and different renal biomarkers for early identification of diabetic nephropathy in type 1 diabetic patients. Open Access Maced J Med Sci. 2017;5(2):188-92.